MALAT1 and lung carcinoma: To further validate Oct4/NEAT1 and Oct4/MALAT1 transcriptional axes in lung cancer patients, we examined RNA expression level of Oct4, NEAT1 and MALAT1 using qRT-PCR analysis of samples from 124 lung cancer patients.